LDH to SGPT (ALT) Ratio: Clinical Significance and Interpretation
The LDH to ALT ratio is not a standard clinical tool in routine liver disease evaluation, but specific ratio patterns can help differentiate certain conditions: an ALT:LDH ratio >9 suggests viral hepatitis while <9 suggests typhoid hepatitis, and an inverted calculation (ALT-LDH index) can predict prognosis in acute liver injury.
Primary Clinical Applications
Differential Diagnosis of Hepatitis
The ALT:LDH ratio (expressed as multiples of upper limit of normal) serves as a discriminatory tool in pediatric hepatitis:
- ALT:LDH ratio >9: Indicates acute viral hepatitis
- ALT:LDH ratio <9: Suggests typhoid hepatitis
This distinction was validated in a pediatric study comparing 29 children with typhoid hepatitis to 29 with acute viral hepatitis 1. This is particularly useful when differentiating between infectious causes of hepatitis in children presenting with elevated transaminases.
Prognostic Assessment in Acute Liver Injury
For patients with acute liver injury (ALT >1000 U/L or INR >1.5), the ALT-LDH index provides prognostic value:
ALT-LDH Index Formula: Serum ALT / (Serum LDH - median of normal LDH range)
- Rapidly increasing index: Predicts conservative survival
- Stagnant or declining index: Indicates poor prognosis and potential need for liver transplantation
By day 3 of hospitalization, this index demonstrates superior prognostic sensitivity and specificity compared to the MELD score 2. The rationale is that LDH elevation reflects hepatic hypoxia from microcirculatory disturbance, a key mechanism in acute liver failure progression.
Mortality Prediction in Acetaminophen-Induced ALF
Elevated LDH alone (without calculating a ratio) predicts mortality in acetaminophen-induced acute liver failure. LDH ≥213.5 U/L independently predicts poor recurrence-free survival and overall survival 3. LDH prognostic value is similar to MELD score and superior to King's College Criteria, with combined MELD + LDH outperforming either alone 3.
Important Caveats and Limitations
Not Part of Standard Guidelines
The 2018 Gut guidelines on abnormal liver blood tests do not recommend LDH as part of initial or routine liver disease evaluation 4. The recommended initial panel includes:
- Bilirubin
- Albumin
- ALT
- ALP (alkaline phosphatase)
- GGT (gamma-glutamyl transferase)
- Full blood count
AST:ALT Ratio Takes Priority
For assessing liver fibrosis risk, AST:ALT ratio >1 indicates advanced fibrosis/cirrhosis and is the validated ratio for routine clinical use 4. This ratio maintains utility even when both values are within normal reference ranges.
Context-Specific Utility
The LDH:ALT ratio should only be applied in specific clinical scenarios:
- Differentiating typhoid from viral hepatitis in endemic areas
- Early prognostication in acute liver injury/failure
- Risk stratification in acetaminophen overdose
Pitfalls to Avoid
- Do not use LDH:ALT ratio for chronic liver disease evaluation - it lacks validation in this setting
- LDH is non-specific - elevations occur in hemolysis, myocardial infarction, malignancy, and muscle injury
- The ratio interpretation differs by clinical context - ensure you're using the correct formula (ALT:LDH vs ALT-LDH index) for the specific clinical question
Practical Algorithm
When to calculate LDH:ALT ratio:
Pediatric hepatitis with unclear etiology → Calculate ALT:LDH ratio (as multiples of ULN) to differentiate viral (>9) from typhoid (<9) 1
Acute liver injury (ALT >1000 or INR >1.5) → Calculate ALT-LDH index on days 1 and 3; declining index warrants early transplant evaluation 2
Acetaminophen overdose with ALF → Measure LDH (not ratio); levels ≥213.5 U/L indicate high mortality risk 3
Routine liver disease workup → Do not calculate this ratio; use AST:ALT ratio instead 4